Sat, Jan 31, 2015, 4:07 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Oclaro, Inc. Message Board

mgm2020 1097 posts  |  Last Activity: 6 hours ago Member since: Mar 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Range Bound

    by paladin_roams 7 hours ago

    Not necessarily. They are most likely having private meetings with investment firms that may be considering taking positions or adding to their position which would lock up more shares and lift the price. The results of the 9200 trials on healthy patients for safety and tolerance will be available soon, and then the myositis program should begin very quickly. And---there are all of the wild cards that come out of the blue like the ones we have had in the last couple of weeks. I don't see the stock remaining down at this level for long.

    Sentiment: Strong Buy

  • Hopefully when the next institutional holdings report comes out we will see a pick-up, which will be a very strong positive for the stock and drop the available float even more from small to tiny. A day like Friday shows that this is NOT a good stock for traders. In fact this stock is more of a trader's nightmare. They would have gotten most of the moves completely wrong and ended up losing quite a bit. They would have missed this one totally.

    Sentiment: Strong Buy

  • I don't see a gap jake. The stock closed at $5.83 Thursday and opened at $5.81 yesterday.

    Sentiment: Strong Buy

  • Reply to

    All this because of The Street?

    by davecarmen48 Jan 30, 2015 1:14 PM

    It's only too late if you're a day trader because the stock will not continue straight up, but it IS going up from here. I can't predict whether it will form a new base in the $6-$6.50 range or continue higher and stabilize in the $7 or $8 range. But, since I strongly believe that their platform will revolutionize cancer monitoring and treatment I think it has a very long way to run. You also have to look at the float, which is tiny. I think institutions will be seriously looking at, and investing in TROV, which will shrink the float even more, and raise the price as they accumulate.

  • Reply to

    mgm trov

    by oilup12345 Jan 30, 2015 12:03 PM
    mgm2020 mgm2020 Jan 30, 2015 2:57 PM Flag

    Saved up for the wedding. Going to RETIRE on the profit from IDRA

    Sentiment: Strong Buy

  • Reply to

    New TROV stock holder

    by maxiedogbark Jan 30, 2015 1:54 PM
    mgm2020 mgm2020 Jan 30, 2015 1:55 PM Flag

    RIGHT!

    Sentiment: Strong Buy

  • and didn't have the research and data to support the move. That time, the stock had been basing at a lower level prior to the move higher, and even though the price dropped back down following that move---it stabilized and formed a new base roughly 50% higher than the previous base. That was a very healthy move and created stability for the past few months. During those last few months the company has presented compelling data at at least 3 prestigious conferences including Piper Jaffray and ASH, announced new collaborations, entered into new cancer detection areas(lung cancer), and is primed and ready for the next breakout to a higher level and new base prior to the full scale rollout. This is called TRACTION.

    Sentiment: Strong Buy

  • Reply to

    carlsh77, aka #$%$ basher, here are the FACTS

    by gfunco1302 Jan 30, 2015 12:23 PM
    mgm2020 mgm2020 Jan 30, 2015 1:41 PM Flag

    Tell us why the company will fail carlsh. What issues do you have with the science and either the TLR 7,8,and 9 agonists or antagonists? And what do you know about the new CEO that we don't? I bet you can't give ONE reason why the company will not succeed-----not one. Wait---I have one-----"because I said so". Wait---here's another---"because I said it's a scam". Ah ah ah-----those don't work. They don't mean anything because YOU said so. We have "science". You know what that is right? It's the course that you kept failing in school---I know---it's very hard to understand---especially for someone with very limited intellect like you. Just ONE carlsh.....

    Sentiment: Strong Buy

  • Reply to

    mgm trov

    by oilup12345 Jan 30, 2015 12:03 PM
    mgm2020 mgm2020 Jan 30, 2015 1:33 PM Flag

    I was out running errands. My son is getting married tomorrow. Rehearsal dinner tonight. Things are getting a little hectic. But I have my daily buy order in for IDRA. I am LOVING the way TROV is trading and moving this year. The chart looks great---and it was just spotlighted as a possible breakout stock by The Street this morning. And they gave a presentation at a key conference in California on Tuesday. Somethings cookin.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jan 30, 2015 1:25 PM Flag

    Well that was just plain silly. I'm thinking more like $10 by 4th of July and $12-$15 by the end of the year.

    Sentiment: Strong Buy

  • Reply to

    All this because of The Street?

    by davecarmen48 Jan 30, 2015 1:14 PM
    mgm2020 mgm2020 Jan 30, 2015 1:24 PM Flag

    I don't think that's why. That has something to do with it--but their chief scientific officer also delivered a presentation at a key conference in California on Tuesday---and who knows what kind of schmoozing and discussions went on behind the scenes. But they are getting closer every day to their platform rolling out and quickly becoming the standard for oncologists to diagnose and monitor their patients. And this is great for everyone-----Doctors will love it and embrace it, patients will love the simplicity and lack of imposition and invasiveness, and THE MARKET will love it due to it's very quick revenue generation and REPEATING revenue due to ongoing monitoring---for LIFE---and that will be reflected in the stock price.

    Sentiment: Strong Buy

  • Reply to

    carlsh77, aka #$%$ basher, here are the FACTS

    by gfunco1302 Jan 30, 2015 12:23 PM
    mgm2020 mgm2020 Jan 30, 2015 1:16 PM Flag

    When did he predict the orphan drug designation for 8400? When did he predict the new CEO? When did he predict the other new additions? Oh yeah---he didn't. Well---if you can't see the positives than you'll be wrong every time---just like carlsh. The thing about the bashers is they not only don't and can't see the positives---but they even deliberately IGNORE them---just like we do to their posts.

    Sentiment: Strong Buy

  • Reply to

    Greens today

    by davecarmen48 Jan 30, 2015 12:59 PM
    mgm2020 mgm2020 Jan 30, 2015 1:13 PM Flag

    I have a nice position---but wish I owned more. Right now I have been adding to my position in IDRA.

    Sentiment: Strong Buy

  • Reply to

    Big move on TROV

    by mehou28 Jan 30, 2015 12:57 PM
    mgm2020 mgm2020 Jan 30, 2015 1:10 PM Flag

    Imagine that! I have been recommending TROV here since it was in the $3's---but since there seems to still be some animosity here towards me because I left KERX a few weeks ago, I know of only a couple of board members that took advantage. Dave C and StockA---this is still just the beginning for a company that will greatly change the way that cancer is diagnosed, monitored, and treated accordingly. Much less invasive and costly than both biopsy and imaging with AT LEAST the same accuracy---and with some mutations---even better! It could DOUBLE from here this year.

    Sentiment: Strong Buy

  • Reply to

    IDRA lost it's mojo

    by carlsh77 Jan 30, 2015 10:09 AM
    mgm2020 mgm2020 Jan 30, 2015 10:53 AM Flag

    I guess you just can't read---or care not to. Didn't you see my post about PCYC?? In Feb of 2011 it was trading at $4.75----and that was down from $8.00 a few months earlier. You and all of your troll and village idiot colleagues who just keep replacing each other on top of the idiot wall were ALL OVER that stock then, I'm sure----and a lot of investors probably thought that was an awful stock and it was never going anywhere. Well------after trading in the $4's for a short time the stock began rising, and rising dramatically-----and is trading at $169 today(in less than 3 years). The SMARTEST INVESTORS and the ones with a time horizon longer than an hour, day, week, or month---were buying----and the more you bought back then, the richer you are today! IDRA has the same potential as PCYC----and will be following the same trajectory. That is why I am taking advantage of this brief pause and accumulating before the REAL climb begins.

    Sentiment: Strong Buy

  • Picked as a possible breakout stock. Once the test panels begin the full rollout process the stock will quickly lift to over $10, and with their very strong IP portfolio and the paradigm shift in cancer monitoring and mutation detection that will also come with the simplicity and precision of the urine test, a takeover will probably not be far behind. Anyone waiting for a pullback will most likely be left out of the fun.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jan 30, 2015 9:59 AM Flag

    That is all correct. IDRA is already past a good deal of the predevelopment phase and into advancing trials already. The partnership with J&J was a major boost for PCYC. When IDRA announces their first partnership with ONE of their compounds, then, you can see by looking at the PCYC chart exactly what will happen. And with the multiple compounds in both the TLR and GSO space, there will most likely be multiple partnerships(a la ISIS) and/or tremendous revenue for IDRA and the shareholders. And---they NOW have the leadership team in place to make everything happen-----beginning in earnest this year.

    Sentiment: Strong Buy

  • Reply to

    Interesting day today...

    by ranger43a Jan 30, 2015 9:08 AM
    mgm2020 mgm2020 Jan 30, 2015 9:27 AM Flag

    Me too. Where are the largest profits and the greatest areas of growth possible? And if there is a global contraction in industrial demand and commodities? The one area of growth that NEVER seems to slow down is health care and medicine---which, according to the FDA approvals of new drugs in 2014, is growing at a record pace-especially for orphan drugs----which did shatter an approval record last year. Looks good for IDRA.

    Sentiment: Strong Buy

  • the price of PCYC was $4.75 on Feb 28th?? 5 cents above IDRA's price right now. PCYC hit $171 yesterday-----with ONE DRUG------ONE!!! Less than 4 years---and an increase in the stock price of $166---and that was definitely NOT a climb straight up----but that is where it is now. Oh----and the price of PCYC hit $8 in October of 2010 and then sank back into the $4's-----sound familiar? How many people bailed then because of that horrible drop? That's what a short-term perspective does for your investments. And there are many more examples like that in biotech.

    Sentiment: Strong Buy

  • Reply to

    Smacking the Bio's again this morning

    by mrborderline Jan 22, 2015 9:59 AM
    mgm2020 mgm2020 Jan 30, 2015 8:57 AM Flag

    Believe it or not---I had PCYC in the low $90's after it pulled back from about $110. But-----I got impatient with it, and that was following Yellen's knockdown of biotech---which she had absolutely no business getting involved with. So---I bailed. One of my biggest OOOPS's ever. Thankfully I poured all of the funds into IDRA, and that was back when it was in the $2's--so it worked out for me-----but I got lucky there. But since then I have added thousands more shares of IDRA---as the stock has been climbing----adding last at $4.70 3 days ago. PCYC is a great stock----and they partnered long ago with Janssen(J&J) providing well needed support and funding. I expect Milano to work the same kinds of partnerships here, and with multiple compounds and platforms dealing with a myriad of conditions---the potential is mind-boggling. Guess what price PCYC was trading at in Februray of 2011???? $4.86---yep $4.86!! Now it's $170---4 years later.

    Sentiment: Strong Buy

OCLR
1.43-0.06(-4.03%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.